文献速递烧伤创面修复

烧伤创面与酶性清创(ED)的过去、现在与未来

Burn Wounds and Enzymatic Debridement (ED)-Past, Present, and Future.
PubMed 文献 · J Burn Care Res · 2024-01-01

本文系统综述了PubMed中关于烧伤创面酶性清创(ED)的实验与临床研究,共分析59篇报告(42项临床研究、17项实验研究),其中46项研究涉及菠萝提取物清创剂,近3年(2020-2023)有23项临床研究报道了菠萝蛋白酶清创(BBD)浓聚物的良好结果。结论认为现有证据不完全支持用BBD替代现行手术标准治疗,但ED是烧伤创面处理中具有高度优势的方式,新近的角质酶和SN514也仍待进一步研究后才能临床采用。

要点

  • 深层烧伤坏死组织切除是烧伤治疗关键,早期削痂植皮虽为标准治疗但存在失血、低体温和误切正常组织等缺点。
  • 系统综述纳入59篇报告,其中46项研究关于菠萝提取物清创剂,近3年(2020-2023)有23项临床研究报道BBD浓聚物结果良好。
  • 现有证据不完全支持用BBD替代手术标准治疗,角质酶和SN514仍待进一步研究后才能临床采用。

核心结论

  • 现有证据不完全支持用菠萝蛋白酶清创(BBD)替代现行手术标准治疗,但ED是烧伤创面处理中具有高度优势的方式。
  • 新近描述的角质酶和SN514也是有前景的新产品,两者在临床采用前仍待进一步研究。

研究设计与样本

  • 对PubMed电子数据库进行系统综述,纳入烧伤创面酶性清创的实验与临床研究,并补充检索初始系统综述可能遗漏的报告。
  • 共获取59篇报告全文进行分析,其中42项临床研究、17项实验研究。

主要发现

  • 59篇报告中有46项研究(11项实验研究、35项临床研究)关于菠萝提取物清创剂。
  • 近3年(2020-2023)共发表23项临床研究,描述菠萝蛋白酶清创(BBD)浓聚物取得了有前景的良好结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Excision of necrotic and devitalized tissues of deep burns is key for optimal care of burn injuries. However, the modality of early tangential excision followed by skin grafting proposed by Zora Janzekovic 5 decades ago was not received initially with great enthusiasm. At present, it developed to become the standard of care (SOC) despite the special expertise it necessitates and the general anesthesia it requires in addition to several drawbacks including excessive blood loss, risk of hypothermia, and most importantly potential excision of normal non-burned tissues. Conservative non-surgical selective enzymatic debridement (ED) at present is becoming more popular as an adjunct or even an alternative approach. METHODS: A systematic review of the PubMed electronic database was conducted to identify all experimental and clinical studies about ED of burn wounds. Additional separate searches were also conducted to identify any reports missed by the initial systematic review. Full texts of 59 reports (42 clinical and 17 experimental studies) were retrieved for analysis. RESULTS: A total of 46 studies (11 experimental and 35 clinical) were about the pineapple extract debriding agent. In total, 23 clinical studies describing promising favorable results with pineapple bromelain-based debridement (BBD) concentrate were published in the last 3 years (2020-2023). CONCLUSION: Though available evidence is not entirely in favor of replacing the current surgical SOC with BBD, it certainly presents ED as a highly advantageous modality for the management of burn wounds. Newly described keratinase and SN514 also are promising new products. They both still await further investigation before being clinically adopted.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Atiyeh B, Makkawi K, Beaineh P, et al. Burn Wounds and Enzymatic Debridement (ED)-Past, Present, and Future. J Burn Care Res. 2024. PMID: 38586910. doi:10.1093/jbcr/irae059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。